United Kingdom
# |
Name |
Total Assets |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 597.00 M
|
Dec. 31, 2023 | USD 28.56 | -4.90% |
|
United Kingdom |
|
2 |
USD 595.34 M
|
Dec. 31, 2023 | USD 14.81 | -2.31% |
|
United Kingdom |
|
3 |
USD 375.38 M
|
Dec. 31, 2023 | USD 2.21 | -3.91% |
|
United Kingdom |
|
4 |
USD 360.25 M
|
Dec. 31, 2023 | USD 14.84 | -2.75% |
|
United Kingdom |
|
5 |
USD 214.51 M
|
Dec. 31, 2023 | USD 0.95 | 0.80% |
|
United Kingdom |
|
6 |
USD 119.37 M
|
Dec. 31, 2023 | USD 5.61 | -4.92% |
|
United Kingdom |
|
7 |
USD 105.89 M
|
Dec. 31, 2023 | USD 0.21 | 6.16% |
|
United Kingdom |
|
8 |
USD 93.12 M
|
Dec. 31, 2023 | USD 0.62 | -2.80% |
|
United Kingdom |
|
9 |
USD 66.50 M
|
Dec. 31, 2023 | USD 3.06 | -8.38% |
|
United Kingdom |
|
10 |
USD 35.38 M
|
Dec. 31, 2023 | USD 1.04 | 1.96% |
|
United Kingdom |
|
11 |
USD 18.10 M
|
Dec. 31, 2023 | USD 0.49 | 0.09% |
|
United Kingdom |
|
12 |
USD 5.33 M
|
Dec. 31, 2023 | USD 0.04 | 0.09% |
|
United Kingdom |
The Clinical Trials company in United Kingdom with the highest Total Assets is Immunocore Holdings plc (NasdaqGS: IMCR) at USD 597.00 M.
The Clinical Trials company in United Kingdom with the lowest Total Assets is GENinCode plc (LSE: GENI.L) at USD 5.33 M.
The top 10 Clinical Trials companies in United Kingdom by Total Assets are Immunocore Holdings plc, Bicycle Therapeutics plc, Autolus Therapeutics plc, Centessa Pharmaceuticals plc, Barinthus Biotherapeutics plc, Silence Therapeutics plc, hVIVO plc, Avacta Group Plc, Mereo BioPharma Group plc and NuCana plc.
The bottom 10 Clinical Trials companies in United Kingdom by Total Assets are GENinCode plc, Cambridge Cognition Holdings Plc, NuCana plc, Mereo BioPharma Group plc, Avacta Group Plc, hVIVO plc, Silence Therapeutics plc, Barinthus Biotherapeutics plc, Centessa Pharmaceuticals plc and Autolus Therapeutics plc.